Navigo (Q3 review): Nascent recovery - Redeye
Bildkälla: Stockfoto

Navigo (Q3 review): Nascent recovery - Redeye

Redeye updates its estimates and valuation following Navigo releasing its Q3 2025 report. Adjusted EBIT beat our projection, and cyclical subsidiaries seem to face a nascent market recovery. Nordisk Bergteknik’s share price has continued to rise since the end of Q3, boding well for NAV growth.

Redeye updates its estimates and valuation following Navigo releasing its Q3 2025 report. Adjusted EBIT beat our projection, and cyclical subsidiaries seem to face a nascent market recovery. Nordisk Bergteknik’s share price has continued to rise since the end of Q3, boding well for NAV growth.
Börsvärldens nyhetsbrev